BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

NORGES BANK's Holding History (CIK: 0001374170)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 111,152 Value ($000) $996 Avg Close $9.31 Range $6.02 - $11.31
Q4 2024
Shares 524,804 Value ($000) $3,947 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 611,900 Value ($000) $4,650 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 651,635 Value ($000) $4,027 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 1,006,029 Value ($000) $5,111 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 2,216,612 Value ($000) $13,278 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 846,612 Value ($000) $5,994 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 846,612 Value ($000) $5,960 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 884,863 Value ($000) $7,380 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 1,152,116 Value ($000) $13,226 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 1,073,116 Value ($000) $13,521 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 1,985,365 Value ($000) $21,005 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 795,528 Value ($000) $12,935 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 717,674 Value ($000) $9,940 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 796,674 Value ($000) $11,448 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 171,351 Value ($000) $2,709 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 171,351 Value ($000) $1,743 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 350,760 Value ($000) $2,613 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 1,032,093 Value ($000) $3,545 Avg Close $4.29 Range $3.30 - $6.03
Q2 2020
Shares 543,493 Value ($000) $2,590 Avg Close $3.99 Range $1.80 - $6.29